Back to search
Rhizomelic Chondrodysplasia Punctata
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rhizomelic Chondrodysplasia Punctata trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rhizomelic Chondrodysplasia Punctata trials you may qualify forThe Peroxisome Biogenesis Disorders (PBD) are a group of inherited disorders due to defects in peroxisome assembly causing complex developmental and metabolic s…
The goal of this registry is to collect medical information on individuals with rhizomelic chondrodysplasia punctata and closely related conditions. The study t…
PPI-1011 is being developed as a docosahexaenoic acid (DHA) containing plasmalogen precursor with good long-term stability, specifically for the treatment of rh…
A prospective, longitudinal observational trial in patients with RCDP. Study participants will be evaluated at baseline and approximately every 6 months by the…